Biomerica, Inc. (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
1.870
-0.040 (-2.09%)
Oct 8, 2026, 1:52 PM EDT - Market open
Biomerica Revenue
In the fiscal year ending May 31, 2026, Biomerica had annual revenue of $4.45M, down -16.16%. Biomerica had revenue of $875.00K in the quarter ending May 31, 2026, with 16.82% growth. That makes Biomerica the 40,306th largest company in the world by revenue and 5,383rd in the United States.
Revenue (ttm)
$4.45M
Revenue Growth
-16.16%
P/S Ratio
1.97
Revenue / Employee
$89,060
Employees
50
Market Cap
8.58M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2026 | 4.45M | -858.00K | -16.16% |
| May 31, 2025 | 5.31M | -104.00K | -1.92% |
| May 31, 2024 | 5.42M | 76.00K | 1.42% |
| May 31, 2023 | 5.34M | -13.53M | -71.71% |
| May 31, 2022 | 18.87M | 11.67M | 162.13% |
| May 31, 2021 | 7.20M | 506.32K | 7.57% |
| May 31, 2020 | 6.69M | 1.49M | 28.69% |
| May 31, 2019 | 5.20M | -363.50K | -6.53% |
| May 31, 2018 | 5.56M | -227.49K | -3.93% |
| May 31, 2017 | 5.79M | 651.85K | 12.68% |
| May 31, 2016 | 5.14M | 177.44K | 3.58% |
| May 31, 2015 | 4.96M | -158.08K | -3.09% |
| May 31, 2014 | 5.12M | -1.35M | -20.89% |
| May 31, 2013 | 6.47M | 391.83K | 6.44% |
| May 31, 2012 | 6.08M | 1.18M | 24.12% |
| May 31, 2011 | 4.90M | -175.85K | -3.46% |
| May 31, 2010 | 5.08M | 140.45K | 2.85% |
| May 31, 2009 | 4.93M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IRIDEX | 51.57M |
| Trinity Biotech | 43.79M |
| Cytosorbents | 37.22M |
| Pulsenmore | 14.13M |
| NeuroOne Medical Technologies | 12.47M |
| Intelligent Bio Solutions | 4.22M |
| IceCure Medical | 3.95M |
| Sintx Technologies | 1.33M |
BMRA News
- 12 days ago - Biomerica files $250M mixed securities shelf - TheFly
- 13 days ago - Biomerica files to sell 1.4M shares of common stock for holders - TheFly
- 5 weeks ago - Biomerica Reports Fiscal 2026 Year-End Financial Results - GlobeNewsWire
- 6 weeks ago - Biomerica prices 1.39M shares at $1.60 in private placement - TheFly
- 6 weeks ago - Biomerica engages B. Riley as its exclusive financial advisor - TheFly
- 6 weeks ago - Biomerica Announces $2.23 Million Financing - GlobeNewsWire
- 4 months ago - Biomerica enters master services agreement with life sciences company - TheFly
- 4 months ago - Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development - GlobeNewsWire